Skip to main content
Erschienen in: Cancer Causes & Control 7/2010

01.07.2010 | Brief report

A case–control study of tobacco use and other non-occupational risk factors for lymphoma subtypes defined by t(14; 18) translocations and bcl-2 expression

verfasst von: Cindy M. Chang, Jane C. Schroeder, Andrew F. Olshan, Cherie H. Dunphy, Wen-Yi Huang, Ralph S. Baric, Kathleen Conway, James R. Cerhan, Charles F. Lynch, Nathaniel Rothman, Kenneth P. Cantor, Aaron Blair

Erschienen in: Cancer Causes & Control | Ausgabe 7/2010

Einloggen, um Zugang zu erhalten

Abstract

Objective

We re-evaluated reported associations between tobacco use and other factors and non-Hodgkin lymphoma (NHL) t(14; 18)-subtypes based on fluorescence in situ hybridization (FISH) assays believed to be more sensitive than polymerase chain reaction (PCR), previously used for detecting t(14; 18).

Methods

Commercial FISH assays and bcl-2 immunostaining were performed on paraffin sections to determine t(14; 18) and bcl-2 case-subtypes. Polytomous logistic regression models estimated associations between NHL case-subtypes (versus 1,245 population-based controls) and tobacco use as well as other factors.

Results

Adjusting for age, state, and proxy status, t(14; 18)-negative NHL was associated with any tobacco use (vs. no tobacco use, OR = 1.9, 95% CI = 1.0–3.5), including current smoking (vs. no cigarette use, OR = 1.9, 95% CI = 1.1–3.2). Tobacco exposures were not clearly associated with t(14; 18)-positive NHL or bcl-2 case-subtypes. Hair-dye use and family history of a hemolymphatic cancer were associated with t(14; 18)-negative NHL, but the number of exposed cases was small.

Conclusions

The association between t(14; 18)-negative NHL and cigarette smoking was unexpected given previous evidence of associations between smoking and follicular lymphoma (which is largely t(14; 18)-positive). Future studies characterizing additional molecular characteristics of t(14; 18)-negative NHL may help determine whether the association with smoking may have been causal versus an artifact of chance or bias.
Literatur
1.
Zurück zum Zitat Bell DA, Liu Y, Cortopassi GA (1995) Occurrence of bcl-2 oncogene translocation with increased frequency in the peripheral blood of heavy smokers. J Natl Cancer Inst 87:223–224CrossRefPubMed Bell DA, Liu Y, Cortopassi GA (1995) Occurrence of bcl-2 oncogene translocation with increased frequency in the peripheral blood of heavy smokers. J Natl Cancer Inst 87:223–224CrossRefPubMed
2.
Zurück zum Zitat Schroeder JC, Olshan AF, Baric R, Dent GA, Weinberg CR, Yount B, Cerhan JR, Lynch CF, Schuman LM, Tolbert PE et al (2002) A case-control study of tobacco use and other non-occupational risk factors for t(14; 18) subtypes of non-Hodgkin’s lymphoma (United States). Cancer Causes Control 13:159–168CrossRefPubMed Schroeder JC, Olshan AF, Baric R, Dent GA, Weinberg CR, Yount B, Cerhan JR, Lynch CF, Schuman LM, Tolbert PE et al (2002) A case-control study of tobacco use and other non-occupational risk factors for t(14; 18) subtypes of non-Hodgkin’s lymphoma (United States). Cancer Causes Control 13:159–168CrossRefPubMed
3.
Zurück zum Zitat Barrans SL, Evans PA, O’Connor SJ, Owen RG, Morgan GJ, Jack AS (2003) The detection of t(14; 18) in archival lymph nodes: development of a fluorescence in situ hybridization (FISH)-based method and evaluation by comparison with polymerase chain reaction. J Mol Diagn 5:168–175PubMed Barrans SL, Evans PA, O’Connor SJ, Owen RG, Morgan GJ, Jack AS (2003) The detection of t(14; 18) in archival lymph nodes: development of a fluorescence in situ hybridization (FISH)-based method and evaluation by comparison with polymerase chain reaction. J Mol Diagn 5:168–175PubMed
4.
Zurück zum Zitat Belaud-Rotureau MA, Parrens M, Carrere N, Turmo M, Ferrer J, de Mascarel A, Dubus P, Merlio JP (2007) Interphase fluorescence in situ hybridization is more sensitive than BIOMED-2 polymerase chain reaction protocol in detecting IGH-BCL2 rearrangement in both fixed and frozen lymph node with follicular lymphoma. Hum Pathol 38:365–372CrossRefPubMed Belaud-Rotureau MA, Parrens M, Carrere N, Turmo M, Ferrer J, de Mascarel A, Dubus P, Merlio JP (2007) Interphase fluorescence in situ hybridization is more sensitive than BIOMED-2 polymerase chain reaction protocol in detecting IGH-BCL2 rearrangement in both fixed and frozen lymph node with follicular lymphoma. Hum Pathol 38:365–372CrossRefPubMed
5.
Zurück zum Zitat Einerson RR, Kurtin PJ, Dayharsh GA, Kimlinger TK, Remstein ED (2005) FISH is superior to PCR in detecting t(14; 18)(q32;q21)-IgH/bcl-2 in follicular lymphoma using paraffin-embedded tissue samples. Am J Clin Pathol 124:421–429CrossRefPubMed Einerson RR, Kurtin PJ, Dayharsh GA, Kimlinger TK, Remstein ED (2005) FISH is superior to PCR in detecting t(14; 18)(q32;q21)-IgH/bcl-2 in follicular lymphoma using paraffin-embedded tissue samples. Am J Clin Pathol 124:421–429CrossRefPubMed
6.
Zurück zum Zitat Godon A, Moreau A, Talmant P, Baranger-Papot L, Genevieve F, Milpied N, Zandecki M, Avet-Loiseau H (2003) Is t(14; 18)(q32;q21) a constant finding in follicular lymphoma? An interphase FISH study on 63 patients. Leukemia 17:255–259CrossRefPubMed Godon A, Moreau A, Talmant P, Baranger-Papot L, Genevieve F, Milpied N, Zandecki M, Avet-Loiseau H (2003) Is t(14; 18)(q32;q21) a constant finding in follicular lymphoma? An interphase FISH study on 63 patients. Leukemia 17:255–259CrossRefPubMed
7.
Zurück zum Zitat Poetsch M, Weber-Matthiesen K, Plendl HJ, Grote W, Schlegelberger B (1996) Detection of the t(14; 18) chromosomal translocation by interphase cytogenetics with yeast-artificial-chromosome probes in follicular lymphoma and nonneoplastic lymphoproliferation. J Clin Oncol 14:963–969PubMed Poetsch M, Weber-Matthiesen K, Plendl HJ, Grote W, Schlegelberger B (1996) Detection of the t(14; 18) chromosomal translocation by interphase cytogenetics with yeast-artificial-chromosome probes in follicular lymphoma and nonneoplastic lymphoproliferation. J Clin Oncol 14:963–969PubMed
8.
Zurück zum Zitat Streubel B, Scheucher B, Valencak J, Huber D, Petzelbauer P, Trautinger F, Weihsengruber F, Mannhalter C, Cerroni L, Chott A (2006) Molecular cytogenetic evidence of t(14; 18)(IGH;BCL2) in a substantial proportion of primary cutaneous follicle center lymphomas. Am J Surg Pathol 30:529–536CrossRefPubMed Streubel B, Scheucher B, Valencak J, Huber D, Petzelbauer P, Trautinger F, Weihsengruber F, Mannhalter C, Cerroni L, Chott A (2006) Molecular cytogenetic evidence of t(14; 18)(IGH;BCL2) in a substantial proportion of primary cutaneous follicle center lymphomas. Am J Surg Pathol 30:529–536CrossRefPubMed
9.
Zurück zum Zitat Cook JR (2004) Paraffin section interphase fluorescence in situ hybridization in the diagnosis and classification of non-hodgkin lymphomas. Diagn Mol Pathol 13:197–206CrossRefPubMed Cook JR (2004) Paraffin section interphase fluorescence in situ hybridization in the diagnosis and classification of non-hodgkin lymphomas. Diagn Mol Pathol 13:197–206CrossRefPubMed
10.
Zurück zum Zitat Medeiros LJ, Carr J (1999) Overview of the role of molecular methods in the diagnosis of malignant lymphomas. Arch Pathol Lab Med 123:1189–1207PubMed Medeiros LJ, Carr J (1999) Overview of the role of molecular methods in the diagnosis of malignant lymphomas. Arch Pathol Lab Med 123:1189–1207PubMed
11.
Zurück zum Zitat Spagnolo DV, Ellis DW, Juneja S, Leong AS, Miliauskas J, Norris DL, Turner J (2004) The role of molecular studies in lymphoma diagnosis: a review. Pathology 36:19–44CrossRefPubMed Spagnolo DV, Ellis DW, Juneja S, Leong AS, Miliauskas J, Norris DL, Turner J (2004) The role of molecular studies in lymphoma diagnosis: a review. Pathology 36:19–44CrossRefPubMed
12.
Zurück zum Zitat Papakonstantinou G, Verbeke C, Hastka J, Bohrer M, Hehlmann R (2001) Bcl-2 expression in non-Hodgkin’s lymphomas is not associated with bcl-2 gene rearrangements. Br J Haematol 113:383–390CrossRefPubMed Papakonstantinou G, Verbeke C, Hastka J, Bohrer M, Hehlmann R (2001) Bcl-2 expression in non-Hodgkin’s lymphomas is not associated with bcl-2 gene rearrangements. Br J Haematol 113:383–390CrossRefPubMed
13.
Zurück zum Zitat Blair A, Linos A, Stewart PA, Burmeister LF, Gibson R, Everett G, Schuman L, Cantor KP (1993) Evaluation of risks for non-Hodgkin’s lymphoma by occupation and industry exposures from a case-control study. Am J Ind Med 23:301–312CrossRefPubMed Blair A, Linos A, Stewart PA, Burmeister LF, Gibson R, Everett G, Schuman L, Cantor KP (1993) Evaluation of risks for non-Hodgkin’s lymphoma by occupation and industry exposures from a case-control study. Am J Ind Med 23:301–312CrossRefPubMed
14.
Zurück zum Zitat Brown LM, Blair A, Gibson R, Everett GD, Cantor KP, Schuman LM, Burmeister LF, Van Lier SF, Dick F (1990) Pesticide exposures and other agricultural risk factors for leukemia among men in Iowa and Minnesota. Cancer Res 50:6585–6591PubMed Brown LM, Blair A, Gibson R, Everett GD, Cantor KP, Schuman LM, Burmeister LF, Van Lier SF, Dick F (1990) Pesticide exposures and other agricultural risk factors for leukemia among men in Iowa and Minnesota. Cancer Res 50:6585–6591PubMed
15.
Zurück zum Zitat Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC et al (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84:1361–1392PubMed Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC et al (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84:1361–1392PubMed
16.
Zurück zum Zitat Chang CM, Schroeder JC, Huang WY, Dunphy CH, Baric RS, Olshan AF et al (2010) Non-Hodgkin lymphoma (NHL) subtypes defined by common translocations: utility of fluorescence in situ hybridization (FISH) in a case-control study. Leuk Res 34:190–195CrossRefPubMed Chang CM, Schroeder JC, Huang WY, Dunphy CH, Baric RS, Olshan AF et al (2010) Non-Hodgkin lymphoma (NHL) subtypes defined by common translocations: utility of fluorescence in situ hybridization (FISH) in a case-control study. Leuk Res 34:190–195CrossRefPubMed
17.
Zurück zum Zitat Jaffe ES, Harris NL, Stein H, Vardiman JW (eds) (2001) Pathology and genetics of tumours of haematopoietic and lymphoid tissues. IARCPress, Lyon Jaffe ES, Harris NL, Stein H, Vardiman JW (eds) (2001) Pathology and genetics of tumours of haematopoietic and lymphoid tissues. IARCPress, Lyon
18.
Zurück zum Zitat SAS. Institute Inc. SAS®: version 9.1. Cary (NC): SAS Institute, Inc., Copyright@2002–2003 SAS. Institute Inc. SAS®: version 9.1. Cary (NC): SAS Institute, Inc., Copyright@2002–2003
19.
Zurück zum Zitat Schroeder JC, Weinberg CR (2001) Use of missing-data methods to correct bias and improve precision in case-control studies in which cases are subtyped but subtype information is incomplete. Am J Epidemiol 154:954–962CrossRefPubMed Schroeder JC, Weinberg CR (2001) Use of missing-data methods to correct bias and improve precision in case-control studies in which cases are subtyped but subtype information is incomplete. Am J Epidemiol 154:954–962CrossRefPubMed
20.
Zurück zum Zitat STATA StataCorp LP (2007) Stata statistical software, 9.0 ed. College Station, TX STATA StataCorp LP (2007) Stata statistical software, 9.0 ed. College Station, TX
21.
Zurück zum Zitat Morton LM, Zheng T, Holford TR, Holly EA, Chiu BC, Costantini AS, Stagnaro E, Willett EV, Dal Maso L, Serraino D et al (2005) Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis. Lancet Oncol 6:469–476CrossRefPubMed Morton LM, Zheng T, Holford TR, Holly EA, Chiu BC, Costantini AS, Stagnaro E, Willett EV, Dal Maso L, Serraino D et al (2005) Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis. Lancet Oncol 6:469–476CrossRefPubMed
22.
Zurück zum Zitat Wang SS, Slager SL, Brennan P, Holly EA, De Sanjose S, Bernstein L, Boffetta P, Cerhan JR, Maynadie M, Spinelli JJ et al (2007) Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the international lymphoma epidemiology consortium (InterLymph). Blood 109:3479–3488CrossRefPubMed Wang SS, Slager SL, Brennan P, Holly EA, De Sanjose S, Bernstein L, Boffetta P, Cerhan JR, Maynadie M, Spinelli JJ et al (2007) Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the international lymphoma epidemiology consortium (InterLymph). Blood 109:3479–3488CrossRefPubMed
23.
Zurück zum Zitat Keller-Byrne JE, Khuder SA, Schaub EA, McAfee O (1997) A meta-analysis of non-Hodgkin’s lymphoma among farmers in the central United States. Am J Ind Med 31:442–444CrossRefPubMed Keller-Byrne JE, Khuder SA, Schaub EA, McAfee O (1997) A meta-analysis of non-Hodgkin’s lymphoma among farmers in the central United States. Am J Ind Med 31:442–444CrossRefPubMed
24.
Zurück zum Zitat Alexander DD, Mink PJ, Adami HO, Chang ET, Cole P, Mandel JS, Trichopoulos D (2007) The non-Hodgkin lymphomas: a review of the epidemiologic literature. Int J Cancer 120(Suppl 12):1–39CrossRefPubMed Alexander DD, Mink PJ, Adami HO, Chang ET, Cole P, Mandel JS, Trichopoulos D (2007) The non-Hodgkin lymphomas: a review of the epidemiologic literature. Int J Cancer 120(Suppl 12):1–39CrossRefPubMed
25.
Zurück zum Zitat Cantor KP, Fraumeni JF Jr (1980) Distribution of non-Hodgkin’s lymphoma in the United States between 1950 and 1975. Cancer Res 40:2645–2652PubMed Cantor KP, Fraumeni JF Jr (1980) Distribution of non-Hodgkin’s lymphoma in the United States between 1950 and 1975. Cancer Res 40:2645–2652PubMed
26.
Zurück zum Zitat Chiu BC, Dave BJ, Blair A, Gapstur SM, Chmiel JS, Fought AJ, Zahm SH, Weisenburger DD (2007) Cigarette smoking, familial hematopoietic cancer, hair dye use, and risk of t(14; 18)-defined subtypes of non-Hodgkin’s lymphoma. Am J Epidemiol 165:652–659CrossRefPubMed Chiu BC, Dave BJ, Blair A, Gapstur SM, Chmiel JS, Fought AJ, Zahm SH, Weisenburger DD (2007) Cigarette smoking, familial hematopoietic cancer, hair dye use, and risk of t(14; 18)-defined subtypes of non-Hodgkin’s lymphoma. Am J Epidemiol 165:652–659CrossRefPubMed
27.
Zurück zum Zitat Herrinton LJ, Friedman GD (1998) Cigarette smoking and risk of non-Hodgkin’s lymphoma subtypes. Cancer Epidemiol Biomark Prev 7:25–28 Herrinton LJ, Friedman GD (1998) Cigarette smoking and risk of non-Hodgkin’s lymphoma subtypes. Cancer Epidemiol Biomark Prev 7:25–28
28.
Zurück zum Zitat Morton LM, Hartge P, Holford TR, Holly EA, Chiu BC, Vineis P, Stagnaro E, Willett EV, Franceschi S, La Vecchia C et al (2005) Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the international lymphoma epidemiology consortium (interlymph). Cancer Epidemiol Biomark Prev 14:925–933CrossRef Morton LM, Hartge P, Holford TR, Holly EA, Chiu BC, Vineis P, Stagnaro E, Willett EV, Franceschi S, La Vecchia C et al (2005) Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the international lymphoma epidemiology consortium (interlymph). Cancer Epidemiol Biomark Prev 14:925–933CrossRef
29.
Zurück zum Zitat Morton LM, Holford TR, Leaderer B, Boyle P, Zahm SH, Zhang Y, Flynn S, Tallini G, Zhang B, Owens PH (2003) Cigarette smoking and risk of non-Hodgkin lymphoma subtypes among women. Br J Cancer 89:2087–2092CrossRefPubMed Morton LM, Holford TR, Leaderer B, Boyle P, Zahm SH, Zhang Y, Flynn S, Tallini G, Zhang B, Owens PH (2003) Cigarette smoking and risk of non-Hodgkin lymphoma subtypes among women. Br J Cancer 89:2087–2092CrossRefPubMed
30.
Zurück zum Zitat Parker AS, Cerhan JR, Dick F, Kemp J, Habermann TM, Wallace RB, Sellers TA, Folsom AR (2000) Smoking and risk of non-Hodgkin lymphoma subtypes in a cohort of older women. Leuk Lymphoma 37:341–349PubMed Parker AS, Cerhan JR, Dick F, Kemp J, Habermann TM, Wallace RB, Sellers TA, Folsom AR (2000) Smoking and risk of non-Hodgkin lymphoma subtypes in a cohort of older women. Leuk Lymphoma 37:341–349PubMed
31.
Zurück zum Zitat Schollkopf C, Smedby KE, Hjalgrim H, Rostgaard K, Gadeberg O, Roos G, Porwit-Macdonald A, Glimelius B, Adami HO, Melbye M (2005) Cigarette smoking and risk of non-Hodgkin’s lymphoma—a population-based case-control study. Cancer Epidemiol Biomark Prev 14:1791–1796CrossRef Schollkopf C, Smedby KE, Hjalgrim H, Rostgaard K, Gadeberg O, Roos G, Porwit-Macdonald A, Glimelius B, Adami HO, Melbye M (2005) Cigarette smoking and risk of non-Hodgkin’s lymphoma—a population-based case-control study. Cancer Epidemiol Biomark Prev 14:1791–1796CrossRef
32.
Zurück zum Zitat Stagnaro E, Ramazzotti V, Crosignani P, Fontana A, Masala G, Miligi L, Nanni O, Neri M, Rodella S, Costantini AS (2001) Smoking and hematolymphopoietic malignancies. Cancer Causes Control 12:325–334CrossRefPubMed Stagnaro E, Ramazzotti V, Crosignani P, Fontana A, Masala G, Miligi L, Nanni O, Neri M, Rodella S, Costantini AS (2001) Smoking and hematolymphopoietic malignancies. Cancer Causes Control 12:325–334CrossRefPubMed
33.
Zurück zum Zitat Stagnaro E, Tumino R, Parodi S, Crosignani P, Fontana A, Masala G, Miligi L, Nanni O, Ramazzotti V, Rodella S (2004) Non-Hodgkin’s lymphoma and type of tobacco smoke. Cancer Epidemiol Biomark Prev 13:431–437 Stagnaro E, Tumino R, Parodi S, Crosignani P, Fontana A, Masala G, Miligi L, Nanni O, Ramazzotti V, Rodella S (2004) Non-Hodgkin’s lymphoma and type of tobacco smoke. Cancer Epidemiol Biomark Prev 13:431–437
34.
Zurück zum Zitat Rauzy O, Galoin S, Chale JJ, Adoue D, Albarede JL, Delsol G, al Saati T (1998) Detection of t(14; 18) carrying cells in bone marrow and peripheral blood from patients affected by non-lymphoid diseases. Mol Pathol 51:333–338CrossRefPubMed Rauzy O, Galoin S, Chale JJ, Adoue D, Albarede JL, Delsol G, al Saati T (1998) Detection of t(14; 18) carrying cells in bone marrow and peripheral blood from patients affected by non-lymphoid diseases. Mol Pathol 51:333–338CrossRefPubMed
35.
Zurück zum Zitat Brown LM, Everett GD, Gibson R, Burmeister LF, Schuman LM, Blair A (1992) Smoking and risk of non-Hodgkin’s lymphoma and multiple myeloma. Cancer Causes Control 3:49–55CrossRefPubMed Brown LM, Everett GD, Gibson R, Burmeister LF, Schuman LM, Blair A (1992) Smoking and risk of non-Hodgkin’s lymphoma and multiple myeloma. Cancer Causes Control 3:49–55CrossRefPubMed
36.
Zurück zum Zitat Florescu A, Ferrence R, Einarson T, Selby P, Soldin O, Koren G (2009) Methods for quantification of exposure to cigarette smoking and environmental tobacco smoke: focus on developmental toxicology. Ther Drug Monit 31:14–30CrossRefPubMed Florescu A, Ferrence R, Einarson T, Selby P, Soldin O, Koren G (2009) Methods for quantification of exposure to cigarette smoking and environmental tobacco smoke: focus on developmental toxicology. Ther Drug Monit 31:14–30CrossRefPubMed
37.
Zurück zum Zitat Shopland D, Burns D, Samet J, Gritz E (1991) Monograph 1: strategies to control tobacco use in the United States: a blueprint for public health action in the 1990’s national cancer institute Shopland D, Burns D, Samet J, Gritz E (1991) Monograph 1: strategies to control tobacco use in the United States: a blueprint for public health action in the 1990’s national cancer institute
39.
Zurück zum Zitat Baccarelli A, Hirt C, Pesatori AC, Consonni D, Patterson DG Jr, Bertazzi PA, Dolken G, Landi MT (2006) t(14; 18) translocations in lymphocytes of healthy dioxin-exposed individuals from Seveso, Italy. Carcinogenesis 27:2001–2007CrossRefPubMed Baccarelli A, Hirt C, Pesatori AC, Consonni D, Patterson DG Jr, Bertazzi PA, Dolken G, Landi MT (2006) t(14; 18) translocations in lymphocytes of healthy dioxin-exposed individuals from Seveso, Italy. Carcinogenesis 27:2001–2007CrossRefPubMed
40.
Zurück zum Zitat Bentham G, Wolfreys AM, Liu Y, Cortopassi G, Green MH, Arlett CF, Cole J (1999) Frequencies of hprt(-) mutations and bcl-2 translocations in circulating human lymphocytes are correlated with United Kingdom sunlight records. Mutagenesis 14:527–532CrossRefPubMed Bentham G, Wolfreys AM, Liu Y, Cortopassi G, Green MH, Arlett CF, Cole J (1999) Frequencies of hprt(-) mutations and bcl-2 translocations in circulating human lymphocytes are correlated with United Kingdom sunlight records. Mutagenesis 14:527–532CrossRefPubMed
41.
Zurück zum Zitat Roulland S, Lebailly P, Lecluse Y, Briand M, Pottier D, Gauduchon P (2004) Characterization of the t(14; 18) BCL2-IGH translocation in farmers occupationally exposed to pesticides. Cancer Res 64:2264–2269CrossRefPubMed Roulland S, Lebailly P, Lecluse Y, Briand M, Pottier D, Gauduchon P (2004) Characterization of the t(14; 18) BCL2-IGH translocation in farmers occupationally exposed to pesticides. Cancer Res 64:2264–2269CrossRefPubMed
Metadaten
Titel
A case–control study of tobacco use and other non-occupational risk factors for lymphoma subtypes defined by t(14; 18) translocations and bcl-2 expression
verfasst von
Cindy M. Chang
Jane C. Schroeder
Andrew F. Olshan
Cherie H. Dunphy
Wen-Yi Huang
Ralph S. Baric
Kathleen Conway
James R. Cerhan
Charles F. Lynch
Nathaniel Rothman
Kenneth P. Cantor
Aaron Blair
Publikationsdatum
01.07.2010
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 7/2010
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-010-9531-8

Weitere Artikel der Ausgabe 7/2010

Cancer Causes & Control 7/2010 Zur Ausgabe

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.